83 - Challenges in Preventing TB Disease Through LTBI Treatment

Thursday, October 17, 2024

3:15 PM – 4:30 PM US PT

Location: 502 A

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Sapna Bamrah Morris, MD

Associate Director of Programs
Centers for Disease Control and Prevention
Dulles, VA, United States
Richard Brostrom, MD-MSPH (he/him/his)

US Pacific Regional TB Medical Officer
Centers for Disease Control and Prevention
Sonya Krishnan, MD, MHS (she/her/hers)

Assistant Professor
Johns Hopkins University School of Medicine
Baltimore, MD, United States

Disclosure(s):

Sapna Bamrah Morris, MD: No financial relationships to disclose

Richard J. Brostrom, MD-MSPH: No financial relationships to disclose

Sonya Krishnan, MD, MHS: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the efficacy of various regimens used to prevent tb disease;
describe risk of progressing to tb disease after completing ltbi treatment;
identify ltbi regimens being evaluated to shorten length of treatment;
recommend the correct ltbi regimens for patients who are infected given various risk factors for progression to tb disease.

Presentations:

3:15 PM – 3:50 PM US PT

TB After 3HP: Assessing the durability of TB prevention in a high-incidence island
Speaker: Richard J. Brostrom, MD-MSPH (he/him/his) – Centers for Disease Control and Prevention
3:50 PM – 4:30 PM US PT

Less is More: Shortening TB Preventive Therapy
Speaker: Sonya Krishnan, MD, MHS (she/her/hers) – Johns Hopkins University School of Medicine